178 related articles for article (PubMed ID: 28237911)
21. Plasma concentrations of granulocyte colony-stimulating factor (G-CSF) in patients with substance use disorders and comorbid major depressive disorder.
Galván ST; Flores-López M; Romero-Sanchiz P; Requena-Ocaña N; Porras-Perales O; Nogueira-Arjona R; Mayoral F; Araos P; Serrano A; Muga R; Pavón FJ; García-Marchena N; de Fonseca FR
Sci Rep; 2021 Jul; 11(1):13629. PubMed ID: 34211033
[TBL] [Abstract][Full Text] [Related]
22. Major depression and comorbid substance use disorders.
Davis L; Uezato A; Newell JM; Frazier E
Curr Opin Psychiatry; 2008 Jan; 21(1):14-8. PubMed ID: 18281835
[TBL] [Abstract][Full Text] [Related]
23. Personality Profile and Clinical Correlates of Patients With Substance Use Disorder With and Without Comorbid Depression Under Treatment.
Marquez-Arrico JE; Río-Martínez L; Navarro JF; Prat G; Adan A
Front Psychiatry; 2018; 9():764. PubMed ID: 30687142
[No Abstract] [Full Text] [Related]
24. Coping among military veterans with PTSD in substance use disorder treatment.
Tyler Boden M; Kimerling R; Kulkarni M; Bonn-Miller MO; Weaver C; Trafton J
J Subst Abuse Treat; 2014 Aug; 47(2):160-7. PubMed ID: 24854218
[TBL] [Abstract][Full Text] [Related]
25. Coping styles in substance use disorder (SUD) patients with and without co-occurring attention deficit/hyperactivity disorder (ADHD) or autism spectrum disorder (ASD).
Kronenberg LM; Goossens PJ; van Busschbach J; van Achterberg T; van den Brink W
BMC Psychiatry; 2015 Jul; 15():159. PubMed ID: 26169586
[TBL] [Abstract][Full Text] [Related]
26. Circadian Functioning and Quality of Life in Substance Use Disorder Patients With and Without Comorbid Major Depressive Disorder.
Hashemzadeh I; Marquez-Arrico JE; Hashemzadeh K; Navarro JF; Adan A
Front Psychiatry; 2021; 12():750500. PubMed ID: 34777054
[No Abstract] [Full Text] [Related]
27. Clinical features, response to treatment and functional outcome of bipolar disorder patients with and without co-occurring substance use disorder: 1-year follow-up.
Mazza M; Mandelli L; Di Nicola M; Harnic D; Catalano V; Tedeschi D; Martinotti G; Colombo R; Bria P; Serretti A; Janiri L
J Affect Disord; 2009 May; 115(1-2):27-35. PubMed ID: 18845344
[TBL] [Abstract][Full Text] [Related]
28. Course and severity of substance abuse among patients with comorbid major depression.
Westermeyer J; Kopka S; Nugent S
Am J Addict; 1997; 6(4):284-92. PubMed ID: 9398926
[TBL] [Abstract][Full Text] [Related]
29. Actor-partner interdependence analysis in depressed patient-caregiver dyads: Influence of emotional intelligence and coping strategies on anxiety and depression.
Marguerite S; Laurent B; Marine A; Tanguy L; Karine B; Pascal A; Xavier Z
Psychiatry Res; 2017 Dec; 258():396-401. PubMed ID: 28890228
[TBL] [Abstract][Full Text] [Related]
30. Change in anxiety sensitivity and substance use coping motives as putative mediators of treatment efficacy among substance users.
Wolitzky-Taylor K; Drazdowski TK; Niles A; Roy-Byrne P; Ries R; Rawson R; Craske MG
Behav Res Ther; 2018 Aug; 107():34-41. PubMed ID: 29852309
[TBL] [Abstract][Full Text] [Related]
31. Independent versus substance-induced major depressive disorders in first-admission patients with substance use disorders: an exploratory study.
Langås AM; Malt UF; Opjordsmoen S
J Affect Disord; 2013 Jan; 144(3):279-83. PubMed ID: 23158758
[TBL] [Abstract][Full Text] [Related]
32. [Self-esteem, coping, perceived social support and substance use in young adults with a cannabis dependence disorder].
Dorard G; Bungener C; Corcos M; Berthoz S
Encephale; 2014 Jun; 40(3):255-62. PubMed ID: 23928065
[TBL] [Abstract][Full Text] [Related]
33. Gender differences in substance abuse treatment and barriers to care among persons with substance use disorders with and without comorbid major depression.
Chen LY; Strain EC; Crum RM; Mojtabai R
J Addict Med; 2013; 7(5):325-34. PubMed ID: 24091763
[TBL] [Abstract][Full Text] [Related]
34. Coping Strategies in Male Patients under Treatment for Substance Use Disorders and/or Severe Mental Illness: Influence in Clinical Course at One-Year Follow-Up.
Marquez-Arrico JE; Río-Martínez L; Navarro JF; Prat G; Forero DA; Adan A
J Clin Med; 2019 Nov; 8(11):. PubMed ID: 31739487
[TBL] [Abstract][Full Text] [Related]
35. Major depressive disorder in adolescents: family psychiatric history predicts severe behavioral disinhibition.
King CA; Knox MS; Henninger N; Nguyen TA; Ghaziuddin N; Maker A; Hanna GL
J Affect Disord; 2006 Feb; 90(2-3):111-21. PubMed ID: 16352346
[TBL] [Abstract][Full Text] [Related]
36. Beck Depression Inventory for depression screening in substance-abusing adolescents.
Subramaniam G; Harrell P; Huntley E; Tracy M
J Subst Abuse Treat; 2009 Jul; 37(1):25-31. PubMed ID: 19339144
[TBL] [Abstract][Full Text] [Related]
37. History of major depressive disorder among smokers in cessation treatment: associations with dysfunctional attitudes and coping.
Kahler CW; Brown RA; Strong DR; Lloyd-Richardson EE; Niaura R
Addict Behav; 2003 Aug; 28(6):1033-47. PubMed ID: 12834649
[TBL] [Abstract][Full Text] [Related]
38. Effects of major depression on remission and relapse of substance dependence.
Hasin D; Liu X; Nunes E; McCloud S; Samet S; Endicott J
Arch Gen Psychiatry; 2002 Apr; 59(4):375-80. PubMed ID: 11926938
[TBL] [Abstract][Full Text] [Related]
39. Major depressive disorder, personality disorders, and coping strategies are independent risk factors for lower quality of life in non-metastatic breast cancer patients.
Brunault P; Champagne AL; Huguet G; Suzanne I; Senon JL; Body G; Rusch E; Magnin G; Voyer M; Réveillère C; Camus V
Psychooncology; 2016 May; 25(5):513-20. PubMed ID: 26356037
[TBL] [Abstract][Full Text] [Related]
40. The effects of substance use disorder on the clinical presentation of anxiety and depression in an outpatient psychiatric clinic.
Tsuang D; Cowley D; Ries R; Dunner DL; Roy-Byrne PP
J Clin Psychiatry; 1995 Dec; 56(12):549-55. PubMed ID: 8530330
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
